<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JHC</journal-id>
<journal-id journal-id-type="hwp">spjhc</journal-id>
<journal-title>Journal of Histochemistry &amp; Cytochemistry</journal-title>
<issn pub-type="ppub">0022-1554</issn>
<issn pub-type="epub">1551-5044</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1369/0022155412453052</article-id>
<article-id pub-id-type="publisher-id">10.1369_0022155412453052</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Imaging Flow Cytometry</article-title>
<subtitle>Coping with Heterogeneity in Biological Systems</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Barteneva</surname><given-names>Natasha S.</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Fasler-Kan</surname><given-names>Elizaveta</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Vorobjev</surname><given-names>Ivan A.</given-names></name>
</contrib>
</contrib-group>
<aff id="aff1-0022155412453052">Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts (NSB)</aff>
<aff id="aff2-0022155412453052">University of Applied Sciences Northwestern Switzerland (FHNW)</aff>
<aff id="aff3-0022155412453052">Institute of Chemistry and Bioanalytics, Muttenz, Switzerland (EF-K)</aff>
<aff id="aff4-0022155412453052">A. N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia (IAV)</aff>
<aff id="aff5-0022155412453052">Department of Cell Biology and Histology, Faculty of Biology, M. V. Lomonosov Moscow State University, Moscow, Russia (IAV)</aff>
<author-notes>
<corresp id="corresp1-0022155412453052">Natasha Barteneva, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston and Department of Pediatrics, Harvard Medical School, D-239, 200 Longwood Avenue, Boston, 02115, MA, USA. E-mail: <email>barteneva@idi.harvard.edu</email></corresp>
<corresp id="corresp2-0022155412453052">Elizaveta Fasler-Kan, University of Applied Sciences Northwestern Switzerland (FHNW), Institute of Chemistry and Bioanalytics, Gruendenstrasse 40, CH-4132, Muttenz, Switzerland. E-mail: <email>elizaveta.fasler@fhnw.ch</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>60</volume>
<issue>10</issue>
<fpage>723</fpage>
<lpage>733</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>5</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>6</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">The Histochemical Society</copyright-holder>
</permissions>
<abstract>
<p>Imaging flow cytometry (IFC) platforms combine features of flow cytometry and fluorescent microscopy with advances in data-processing algorithms. IFC allows multiparametric fluorescent and morphological analysis of thousands of cellular events and has the unique capability of identifying collected events by their real images. IFC allows the analysis of heterogeneous cell populations, where one of the cellular components has low expression (&lt;0.03%) and can be described by Poisson distribution. With the help of IFC, one can address a critical question of statistical analysis of subcellular distribution of proteins in a cell. Here the authors review advantages of IFC in comparison with more traditional technologies, such as Western blotting and flow cytometry (FC), as well as new high-throughput fluorescent microscopy (HTFM), and discuss further developments of this novel analytical technique.</p>
</abstract>
<kwd-group>
<kwd>imaging flow cytometry</kwd>
<kwd>flow cytometry</kwd>
<kwd>biological heterogeneity</kwd>
<kwd>fluorescence</kwd>
<kwd>cellular morphology</kwd>
<kwd>Poisson distribution</kwd>
<kwd>single cell</kwd>
<kwd>high-throughput fluorescent microscopy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Several types of high-throughput instrumentation for analyzing and quantifying different aspects of cell biology are now available. They include plate readers, sequencing platforms, DNA, RNA and protein microarrays, Western blotting, flow cytometers, and so on. However, many platforms allow readouts only on the population level. Technologies that allow readout at the single-cell level include flow cytometry (FC), imaging cytometry, and different automated microscopy setups. These platforms are essential for assaying diversity within cell populations and searching for rare cells with specific features (stem cells, etc.).</p>
<p>Cytometry assays are sensitive, fluorescence-based methods aimed at determining a molecular phenotype of single cells. They can be multiparametric, multiplexed, quantitative, and qualitative. They can also be extracted as a result of kinetic or single end-point measurements. FC allows for the simultaneous quantification of multiple fluorescent emissions and the scattered light of single cells acquired in the laminar flow of cell suspension. FC is a technology that measures the cellular properties (protein expression, siRNA expression, etc.) in a snapshot of the entire population (<xref ref-type="bibr" rid="bibr77-0022155412453052">Shapiro 2005</xref>; <xref ref-type="bibr" rid="bibr35-0022155412453052">Huang S 2009</xref>). Imaging cytometry (IC) is represented by two different types of technology: 1) high-throughput microscopy and laser scanning cytometry, which interrogates cells or tissue specimens <italic>in situ</italic> positioned on the microscope slide or in the microplate wells (<xref ref-type="bibr" rid="bibr38-0022155412453052">Kamentsky and Kamentsky 1991</xref>; <xref ref-type="bibr" rid="bibr16-0022155412453052">Darzynkiewicz et al. 1999</xref>; <xref ref-type="bibr" rid="bibr28-0022155412453052">Gerstner et al. 2004</xref>; <xref ref-type="bibr" rid="bibr82-0022155412453052">Terjung et al. 2010</xref>; <xref ref-type="bibr" rid="bibr33-0022155412453052">Henriksen et al. 2011</xref>; <xref ref-type="bibr" rid="bibr75-0022155412453052">Rimon and Schuldiner 2011</xref>), and 2) imaging flow cytometry (IFC), which interrogates cells and cellular aggregates in the laminar flow (<xref ref-type="bibr" rid="bibr54-0022155412453052">McGrath et al. 2008</xref>).</p>
<p>The most important difference between FC and IFC depends on whether the fluorescence data of the cell suspension are obtained with cell morphology or from fluorescence pulse-analysis. IFC allows for the acquisition and identification of tens of thousands of cellular events based on their fluorescent and morphological parameters. The first and unique IFC instrument—Imagestream 100 (IS100)—was introduced in 2005, and the next generation of Imagestream imaging flow cytometers (IS-X) was recently launched by Amnis Corp. (Seattle, WA) (<xref ref-type="bibr" rid="bibr6-0022155412453052">Basiji et al. 2007</xref>).</p>
<sec id="section1-0022155412453052">
<title>IFC in the Evaluation of Cellular Heterogeneity</title>
<p>IFC allows for the evaluation of morphological and fluorescent data at a single-cell as well as at a population level (<xref ref-type="fig" rid="fig1-0022155412453052">Figure 1</xref>). IFC combines the statistical advantage of FC with the ability to identify each event based on a real image, which allows it to analyze protein expression in single cells in heterogeneous cell populations, where the level of expression of one of the proteins is low and could be described by Poisson distribution (rare cell subpopulations with &lt;0.01% of expression). The multiple applications of IFC include analysis of nuclear-cytoplasmic translocation (<xref ref-type="bibr" rid="bibr4-0022155412453052">Arechiga et al. 2005</xref>; <xref ref-type="bibr" rid="bibr23-0022155412453052">Fanning et al. 2006</xref>; <xref ref-type="bibr" rid="bibr15-0022155412453052">Danis et al. 2008</xref>), quantification of apoptosis based on the changes in nuclear morphology (<xref ref-type="bibr" rid="bibr26-0022155412453052">George et al. 2004</xref>; <xref ref-type="bibr" rid="bibr32-0022155412453052">Henery et al. 2008</xref>; <xref ref-type="bibr" rid="bibr39-0022155412453052">Khuda et al. 2008</xref>), and quantitative analysis of internalized bacteria and protozoan parasites (<xref ref-type="bibr" rid="bibr57-0022155412453052">Muskavitch et al. 2008</xref>; <xref ref-type="bibr" rid="bibr9-0022155412453052">Bisha and Brehm-Stecher 2009</xref>; <xref ref-type="bibr" rid="bibr69-0022155412453052">Ploppa et al. 2011</xref>). In recent years, IFC was also employed for the evaluation of asymmetric cell division (<xref ref-type="bibr" rid="bibr24-0022155412453052">Filby et al. 2011</xref>), internalization of CypHer5E-conjugated antibodies and PKH-labeled exosomes (<xref ref-type="bibr" rid="bibr89-0022155412453052">Xu et al. 2010</xref>; <xref ref-type="bibr" rid="bibr86-0022155412453052">Vallhov et al. 2011</xref>), intercellular communication by exchange of cytoplasmic material (<xref ref-type="bibr" rid="bibr21-0022155412453052">Domhan et al. 2011</xref>), analysis of cell interactions and immune synapse (<xref ref-type="bibr" rid="bibr1-0022155412453052">Ahmed et al. 2009</xref>; <xref ref-type="bibr" rid="bibr63-0022155412453052">Ouk et al. 2011</xref>), and some other experimental applications (<xref ref-type="bibr" rid="bibr70-0022155412453052">Ponomarev et al. 2011</xref>).</p>
<fig id="fig1-0022155412453052" position="float">
<label>Figure 1.</label>
<caption>
<p>A typical workflow for image flow cytometry.</p>
</caption>
<graphic xlink:href="10.1369_0022155412453052-fig1.tif"/>
</fig>
<p>The cell populations are heterogeneous with respect to cell cycle phase, size, volume, physiological state, and their individual development history (<xref ref-type="bibr" rid="bibr52-0022155412453052">Lloyd et al. 2000</xref>; <xref ref-type="bibr" rid="bibr37-0022155412453052">Kaern et al. 2005</xref>; <xref ref-type="bibr" rid="bibr67-0022155412453052">Pilborough et al. 2009</xref>). In a clonal population, large variations in phenotype may be the result of fluctuating gene expressions (<xref ref-type="bibr" rid="bibr40-0022155412453052">Kim et al. 1998</xref>; <xref ref-type="bibr" rid="bibr67-0022155412453052">Pilborough et al. 2009</xref>; <xref ref-type="bibr" rid="bibr19-0022155412453052">Dietmair et al. 2012</xref>). Emerging fundamental research on bacteria (<xref ref-type="bibr" rid="bibr22-0022155412453052">Elowitz et al. 2002</xref>; <xref ref-type="bibr" rid="bibr65-0022155412453052">Ozbudak et al. 2002</xref>; <xref ref-type="bibr" rid="bibr90-0022155412453052">Yu et al. 2006</xref>) and, more recently, on yeast and mammalian cells (<xref ref-type="bibr" rid="bibr58-0022155412453052">Newman et al. 2006</xref>; <xref ref-type="bibr" rid="bibr73-0022155412453052">Raj et al. 2006</xref>; <xref ref-type="bibr" rid="bibr78-0022155412453052">Sigal et al. 2006</xref>; <xref ref-type="bibr" rid="bibr12-0022155412453052">Chang et al. 2008</xref>) shows that protein expressions can have significant variations inside clones of genetically identical cells (intraclonal variation).</p>
<p>The important advantage of cytometric methods over Western blotting and gel-shift assay is that they efficiently overcome the heterogeneity drawback, allowing the data collection of a number of cell populations without averaging the signal intensities. When measuring the average signal intensity, information regarding cell subpopulations of heterogeneous populations can be missed (<xref ref-type="bibr" rid="bibr35-0022155412453052">Huang S 2009</xref>). For example, when a 25% decrease in signal intensity is observed with Western blotting, it is impossible to tell, if this results from a 25% reduction in 100% of the cell population or a 50% reduction in only 50% of the population. To overcome this drawback, a combination of Western blotting and cell sorting is used.</p>
<p>Also, the amount of cells needed for Western blotting analysis is in the range of 5 × 10<sup>5</sup>–10<sup>6</sup> cells per sample, making it practically useless for the analysis of small and rare subpopulations (a rare population being &lt;0.03%). Microarrays and two-dimensional gels are also biased toward more abundant genes (<xref ref-type="bibr" rid="bibr53-0022155412453052">Lu and King 2009</xref>). Although FC can identify and sort rare cell populations with high speed, dealing with rare cell detection using this approach is plagued by the contamination of false-positive events due to autofluorescence, nonspecific immunostaining, and cell aggregates (<xref ref-type="bibr" rid="bibr72-0022155412453052">Radbruch and Recktenwald 1995</xref>). For rare cell detection, the following parameters are considered important: 1) the ability of the instrument to process large numbers of cells, 2) the number of cells analyzed by instrument per unit of time, 3) the sensitivity of the instrument, 4) the specificity of the assay, and 5) the consistency of the instrument performance.</p>
<p>We had difficulties analyzing the large, 100K files using the IDEAS software that came with the IS-100. However, IFC is very helpful in identifying and characterizing small populations of cells, such as the low percentage population of cells that forms an immune synapse in our research of CTL-macrophage interaction of an HIV infection (<xref ref-type="bibr" rid="bibr1-0022155412453052">Ahmed et al. 2009</xref>).</p>
<p>Recently, IFC, combined with cell sorting preenrichment, was successfully employed for the identification and characterization of a novel pluripotent population of very small embryonic-like stem cells (VSELs) in human and animal tissues (<xref ref-type="bibr" rid="bibr47-0022155412453052">Kucia et al. 2006</xref>; <xref ref-type="bibr" rid="bibr92-0022155412453052">Zuba-Surma, Klich, et al. 2009</xref>; <xref ref-type="bibr" rid="bibr94-0022155412453052">Zuba-Surma, Kucia, Rui, et al. 2009</xref>). According to <xref ref-type="bibr" rid="bibr93-0022155412453052">Zuba-Surma, Kucia, Ratajczak, et al. (2009)</xref>, the frequency of VSELs in murine adult spleen (1 × 10<sup>8</sup> cells) was 3.9 × 10<sup>3</sup>, which corresponds to approximately one cell per 2.5 × 10<sup>4</sup> (0.25% of cell population) and even lower in other adult murine organs. IFC is also helpful for the analysis of rare cell populations (&lt;0.01%) after cell sorting.</p>
</sec>
<sec id="section2-0022155412453052">
<title>IFC in Signal Transduction Research</title>
<p>Strategies to monitor and manipulate individual signaling pathways and the modification of target protein properties by reversible phosphorylation can offer valuable tools to investigate the precise role of signal transduction pathways in the pathogenesis and progression of human diseases. The phosphorylation of a protein is the principal cellular mechanism regulating protein function and is controlled by protein kinases and phosphatases. Therefore, monitoring kinase and phosphatase activities is crucial to understanding signal transduction pathways. The Western blot is currently regarded as the most versatile and convenient assay for quantifying signaling activities, partly due to the successful use of short synthetic peptides to produce epitope-targeted antibodies for this platform. However, using Western blot, multiple signaling activities cannot be simultaneously quantified, and the signal intensities of various subpopulations can not be differentiated. Other drawbacks of the Western blotting approach are the necessity of cell lysis and solubilization of the samples. The solubilization step is required to release the protein of interest from its membrane environment and may lead to artificial associations and oligomerization of proteins and other artifacts. Also, Western blotting requires a significant amount of cells (5 × 10<sup>5</sup>–10<sup>6</sup> per line), and in many cases, preliminary immunomagnetic purification and/or fluorescent-activated cell sorting (FACS) is needed. Many proteins involved in signal transduction pathways are expressed at low levels and cannot be evaluated by standard Western blotting techniques. Recently, new approaches, such as antibody co-localization microarrays and reverse protein assays, have been developed (<xref ref-type="bibr" rid="bibr42-0022155412453052">Kornblau et al. 2009</xref>; <xref ref-type="bibr" rid="bibr10-0022155412453052">Brennan et al. 2010</xref>; <xref ref-type="bibr" rid="bibr68-0022155412453052">Pla-Roca et al. 2012</xref>). Reverse protein arrays can determine the levels of multiple phosphoproteins in cell lysates in a high-throughput fashion on chips, but it is impossible to differentiate signal intensities of individual cells and discrete cell subsets using these techniques (<xref ref-type="bibr" rid="bibr88-0022155412453052">Wu et al. 2010</xref>).</p>
<p>An increasingly common technique to characterize signal transduction pathways relies on FC. FC has been shown to provide quantitative data for measuring signaling activities similar to the Western blot (<xref ref-type="bibr" rid="bibr45-0022155412453052">Krutzik and Nolan 2003</xref>; <xref ref-type="bibr" rid="bibr44-0022155412453052">Krutzik et al. 2004</xref>, <xref ref-type="bibr" rid="bibr46-0022155412453052">2011</xref>) and is also capable of measuring multiple signaling activities in single cells on a population level. FC has been most commonly used for the analysis of multiple kinases (such as the JAK-STAT pathway) and phosphatases in response to different signaling (<xref ref-type="bibr" rid="bibr66-0022155412453052">Perez et al. 2004</xref>; <xref ref-type="bibr" rid="bibr31-0022155412453052">Heller et al. 2006</xref>; <xref ref-type="bibr" rid="bibr81-0022155412453052">Teofili et al. 2007</xref>; <xref ref-type="bibr" rid="bibr43-0022155412453052">Kotecha et al. 2008</xref>; <xref ref-type="bibr" rid="bibr61-0022155412453052">Oh et al. 2010</xref>). The major drawback in using FC to characterize different signal transduction pathways is the lack of a reliably wide panel of antibodies with high specificity. Antibodies are frequently cross-reactive, but in FC, there is no way to filter out “cross-reactivity” (<xref ref-type="bibr" rid="bibr60-0022155412453052">Oberprieler and Tasken 2011</xref>). Currently, numerous antibodies against phosphoepitopes are under development in several laboratories (<xref ref-type="bibr" rid="bibr43-0022155412453052">Kotecha et al. 2008</xref>; <xref ref-type="bibr" rid="bibr50-0022155412453052">Lee et al. 2008</xref>; <xref ref-type="bibr" rid="bibr59-0022155412453052">Oberprieler et al. 2010</xref>).</p>
<p>The signal-induced nuclear-cytoplasmic translocation of key signal transduction molecules (such as NF-κB, FOX-p3, Smad, and others) is a common phenomenon in many pathways. FC is unable to provide information about the subcellular localization of the fluorescent signal. To obviate the requirement for determining nuclear localization for molecules in the NF-κB pathway, the FC approach relies on the detection of phospho-specific intermediaries (Phospho-p65) (<xref ref-type="bibr" rid="bibr5-0022155412453052">Armstrong et al. 2006</xref>). Also, FC is not capable of providing information about the interrelationship of signaling activities at the intracellular level. The FC study of signaling in adhesive cells is at a disadvantage in that cells have to be detached into a single suspension before fixation. Also, the Western blotting of adherent cells in many cases requires preliminary cell sorting to enrich for a certain cell population; this situation is quite common in the field of signal transduction.</p>
<p>Traditionally, transport between the nucleus and the cytoplasm has been studied using subcellular fractionation followed by Western blotting and/or fluorescent microscopy (<xref ref-type="bibr" rid="bibr76-0022155412453052">Shakulov et al. 2000</xref>; <xref ref-type="bibr" rid="bibr91-0022155412453052">Zhou et al. 2006</xref>) and, recently, by automated high-throughput microscopy systems (<xref ref-type="bibr" rid="bibr75-0022155412453052">Rimon and Schuldiner 2011</xref>). For quantitative measurements of protein distribution, the fluorescent intensities of the nucleus and cytoplasm in the fluorescent microscope are usually limited to 50 to 100 cells per experiment due to the small frame size. However, the major advantage of the light microscopy approach is spatial precision, which is being further developed with the implementation of super-resolution techniques (reviewed by <xref ref-type="bibr" rid="bibr34-0022155412453052">Huang B et al. 2009</xref>). Also, measurements can be made in live, functioning cells and directly correlated with single molecules’ trajectories in real time (<xref ref-type="bibr" rid="bibr85-0022155412453052">Tu and Musser 2011</xref>).</p>
<p>IFC allows for the quantitation of bidirectional trafficking of transcriptional regulators from the nucleus to the cytoplasm inside the cell, with a maximum 60× magnification (for IS-X; 40× for IS-100). The approach of image analysis to nuclear-cytoplasmic translocation used in IFC includes the initial identification and segmentation of single cells, and then the signal intensities are summed in the nuclear and cytoplasmic regions; the latter is defined as the whole cell body minus the nuclear region. This is important for the precise identification of individual cells in nuclear translocation assays. On the other hand, it is different from conventional high-throughput imaging, where signal intensities are summed in the nuclear regions plus the cytoplasmic regions, defined by an annulus set around each cell (<xref ref-type="bibr" rid="bibr20-0022155412453052">Ding et al. 1998</xref>; <xref ref-type="bibr" rid="bibr64-0022155412453052">Ozaki et al. 2010</xref>). IDEAS software, developed by Amnis Corp, is capable of calculating nuclear-cytoplasmic translocation based on the degree of co-localization of DNA markers and the protein of interest (<xref ref-type="bibr" rid="bibr27-0022155412453052">George et al. 2006</xref>). The similarity score is derived from Pearson’s correlation coefficient (pixel-by-pixel correlation of the NF-κB and nuclear dye-image pair within the nuclear morphology mask dilated by one pixel), and the cross-correlation methods have been used to estimate the translocation of NF-κB and other transcription factors (FOX-p3, p65, interferon regulatory factor-7 [IRF-7]) (<xref ref-type="bibr" rid="bibr4-0022155412453052">Arechiga et al. 2005</xref>; <xref ref-type="bibr" rid="bibr23-0022155412453052">Fanning et al. 2006</xref>; <xref ref-type="bibr" rid="bibr15-0022155412453052">Danis et al. 2008</xref>; <xref ref-type="bibr" rid="bibr55-0022155412453052">Maguire et al. 2011</xref>). IFC is particularly valuable for signal transduction analysis in 1) experiments employing cells with low levels of expression of the protein of interest and 2) cellular populations with a particularly wide range of responses to a signal (<xref ref-type="bibr" rid="bibr27-0022155412453052">George et al. 2006</xref>).</p>
</sec>
<sec id="section3-0022155412453052">
<title>Elimination of False-Positive and False-Negative Events with IFC</title>
<p>A limitation of FC as a method is that it can create “false-positive” heterogeneity due to staining and sample preparation artifacts resulting from cross-reactivity of antibodies, as well as the absence of morphological information (<xref ref-type="bibr" rid="bibr49-0022155412453052">Lambert and Desbarats 2007</xref>; <xref ref-type="bibr" rid="bibr48-0022155412453052">Kuonen et al. 2010</xref>). Dead cell exclusion and multiple-event discrimination using gating on light-scatter dual-parameter dot blots alleviate but do not completely eliminate the problem. IFC should be a method of choice for the validation of antibody specificity and cross-reactivity. <xref ref-type="bibr" rid="bibr63-0022155412453052">Ouk et al. (2011)</xref> used IFC to demonstrate that adhesion of platelets on the surface of leukocytes is likely to be responsible for false-positive expressions of platelet markers on leukocytes determined by FC. Standard gating exclusions of multiaggregates in FC analyses (FSC-W/FSC-H) do not work in this case because of the relatively small size of the platelets attached (2–3 µ).</p>
<p>Most false-positive events are known to be associated with apoptosis, cytotoxicity, and cell differentiation, including kinases and protein phosphatases (<xref ref-type="bibr" rid="bibr14-0022155412453052">Crisman et al. 2007</xref>). During apoptosis, detection of false-positive events can occur due to several factors: 1) Apoptotic bodies and microparticles can adhere to the surface of live, non-apoptotic cells; 2) cells stained with an apoptotic marker could adhere to a normal cell; 3) cells can phagocytize a fluorescently labeled apoptotic body and/or cell fragments; and 4) apoptotic bodies and/or cell fragments can be counted as apoptotic cells (<xref ref-type="bibr" rid="bibr7-0022155412453052">Bedner et al. 1998</xref>, <xref ref-type="bibr" rid="bibr8-0022155412453052">1999</xref>; <xref ref-type="bibr" rid="bibr17-0022155412453052">Darzynkiewicz et al. 2001</xref>). Because IFC includes real imaging of each fluorophore distribution in the cell, it is possible to determine if fluorophores are located outside the area of the cell or at the expected location (membrane for Annexin V assay, nucleus for terminal deoxynucleotidyl transferase dUTP nick end labeling [TUNEL] assay, cytoplasm for caspase-3 substrate) (<xref ref-type="bibr" rid="bibr32-0022155412453052">Henery et al. 2008</xref>). Another example of false- negative events is that some cells in the population can lose the apoptotic marker due to the loss of membrane integrity. It is also important that most if not all FC techniques for the detection of apoptosis (such as TUNEL method, conventional apoptosis assays using propidium iodide, subG1 DNA content determination, etc.) also detect necrosis and other cellular processes (<xref ref-type="bibr" rid="bibr3-0022155412453052">Ansari et al. 1993</xref>; <xref ref-type="bibr" rid="bibr51-0022155412453052">Li et al. 1995</xref>; <xref ref-type="bibr" rid="bibr25-0022155412453052">Frankfurt et al. 1996</xref>; <xref ref-type="bibr" rid="bibr74-0022155412453052">Rieger et al. 2010</xref>; <xref ref-type="bibr" rid="bibr11-0022155412453052">Bucur et al. 2012</xref>). IFC is capable of discriminating false events on the basis of cell images and providing morphological information on these cells (nuclear fragmentation, membrane blebbing, etc.).</p>
</sec>
<sec id="section4-0022155412453052">
<title>Advantages of IFC</title>
<p>The FC statistical advantage comes at the price of missing information because FC measures total fluorescence of individual cells selected by sophisticated gating from a cell population. As a result, fluctuations in the protein and gene expression may be due to a difference in cell volumes (<xref ref-type="bibr" rid="bibr58-0022155412453052">Newman et al. 2006</xref>; <xref ref-type="bibr" rid="bibr87-0022155412453052">Volfson et al. 2006</xref>; <xref ref-type="bibr" rid="bibr84-0022155412453052">Tsuru et al. 2009</xref>). A common method to reduce cell variability relies on “gating” (i.e., creating sequential gates in the FSC-A/SSC-A and FSC-H/FSC-W dot blots and discarding all the cells that fall outside the chosen gates, hence reducing variability in the cellular optical properties). In practice, FC does not allow for the discrimination between multiple events and large cells, masking potentially relevant cells and biasing results. Excluding events outside scattered light gates can drastically reduce the analyzed sample size, particularly in the analysis of detached or digested cells, enzymatically treated with trypsin or collagenase, and ignore the ungated cell population by masking potentially relevant cellular events. Recently, <xref ref-type="bibr" rid="bibr41-0022155412453052">Knijnenburg et al. (2011)</xref> introduced a correction for phenotypic variability based on the regression model that uses all the cells in the sample to normalize cell size and granularity effects on fluorescence intensity. On the other hand, IFC offers an alternative to gating on the basis of light scattering such that gating uses an aspect ratio of cells (a ratio of cell diameters), diameter and cell volume, and other morphological features.</p>
<p>The pool of antibodies that can be used for IFC includes FC-quality antibodies, as well as polyclonal antibodies used for immunoprecipitation and immunohistochemistry assays (such as rabbit polyclonal NFκB p65 antibody and anti-IRF-7 [Santa Cruz Biotechnology, Santa Cruz, CA]) (<xref ref-type="bibr" rid="bibr23-0022155412453052">Fanning et al. 2006</xref>; <xref ref-type="bibr" rid="bibr83-0022155412453052">Tibrewal et al. 2008</xref>).</p>
<p>Image processing needs to be adapted to each new assay developed and therefore is the bottleneck of high-throughput imaging technology (<xref ref-type="bibr" rid="bibr80-0022155412453052">Starkuviene and Pepperkok 2007</xref>). The IS-instruments analyze cells flowing in suspension and collect dark field, bright field, and multiple fluorescent parameters (<xref ref-type="bibr" rid="bibr6-0022155412453052">Basiji et al. 2007</xref>). The greatest advantage of IFC compared with the FC is its unique ability to identify collected events by their real images: For each event displayed on a two-dimensional dot as a “dot,” IDEAS software retrieves a real image of the event. The reverse identification of cellular events on a dot blot is also possible. This capability is crucial for characterization and identification of cellular subpopulations and for identifying false-positive and false-negative events. IFC allows for simultaneous analysis of fluorescent and morphological parameters, which is important for monitoring different processes together such as apoptosis and autophagy (<xref ref-type="bibr" rid="bibr18-0022155412453052">De la Calle et al. 2011</xref>). The resolution of images is limited by 0.5-µ pixels in IS-100 and 0.3-µ pixels in IS-X (when using 60× objective), which allows for the quantification of many cellular parameters, such as size, volume, shape, contrast, spot count, and texture. The IDEAS software gives researchers the capability to analyze acquired cellular images while using bivariate plots and histograms, as well as a sequential gating strategy. It is also possible to create new, complex features using Boolean logic and the combination of two-dimensional masks (such as morphology masks, intensity threshold masks, spot masks, and others). The detailed description of individual masks and features can be found on the company site (<ext-link ext-link-type="uri" xlink:href="http://www.amnis.com">www.amnis.com</ext-link>). Moreover, the IDEAS software has the additional option of defining populations using a gallery of individual images. Overall, the IDEAS software used in IS instruments provides a unique approach allowing the investigator to quickly change critical parameters during the analysis of cellular populations. It is more user-friendly than other currently available image analysis programs that are used in microscopy (Metamorph, ImageJ, etc.), and analysis performed by IDEAS does not require creating scripts or using special programming skills.</p>
<p>Because of the ability to collect real images, IFC also has an advantage in the statistical analysis of not only single cellular events but also cell aggregate content and the study of cell-cell interactions. IFC allows for the analysis of tens of thousands of cellular events versus high-throughput automated fluorescent microscopy, which is usually limited by parallel analysis of several hundred to a few thousand events (<xref ref-type="bibr" rid="bibr82-0022155412453052">Terjung et al. 2010</xref>). For example, quantitative analysis of microaggregates of leukocytes and platelets (<xref ref-type="bibr" rid="bibr29-0022155412453052">Goetz et al. 2005</xref>) achieved with light microscopy was limited by analysis of 50 aggregates per experiment. FC analysis of aggregates, the most widely used method of aggregate detection, provides information only about the level of fluorescent intensity of the aggregate subpopulation defined by the coexpression of platelet and leukocyte (or monocyte) markers (<xref ref-type="bibr" rid="bibr30-0022155412453052">Harding et al. 2007</xref>; <xref ref-type="bibr" rid="bibr36-0022155412453052">Izzi et al. 2007</xref>; <xref ref-type="bibr" rid="bibr2-0022155412453052">Alberti et al. 2009</xref>; <xref ref-type="bibr" rid="bibr79-0022155412453052">Singh et al. 2012</xref>). FC is not able to provide information about morphology and quantitative cellular content of mixed aggregates. <xref ref-type="bibr" rid="bibr63-0022155412453052">Ouk et al. (2011)</xref> used IFC to quantitatively assess the number of adherent platelets to neutrophils and monocytes, to visualize and further confirm mixed aggregates forming during different experimental conditions. The IFC approach could be a method of choice in the study of platelet-leukocyte interactions leading to the formation of mixed aggregates.</p>
<p>Analysis of cell interactions, such as forming immunological synapses with the help of IFC, also allows overcoming limitations of current imaging techniques, such as difficulty in objectively finding rare events, limited statistics, and sample photobleaching during fluorescent microscopy sessions (<xref ref-type="bibr" rid="bibr1-0022155412453052">Ahmed et al. 2009</xref>). Using IFC, we were able to analyze thousands of T cell–macrophage conjugates for each experimental point (<xref ref-type="bibr" rid="bibr1-0022155412453052">Ahmed et al. 2009</xref>). The same methodology could also be used to evaluate the co-localization and movement of molecules in the interactions between antigen-specific cells and target cells and/or between pathogen and immune cells.</p>
</sec>
<sec id="section5-0022155412453052">
<title>Challenges Associated with IFC Studies</title>
<p>The IFC research discussed in the previous sections provided a lot of new information about protein expression, signaling pathways, and cellular interactions. Nevertheless, there appears to be a number of technical and experimental limitations, all of which should be considered when planning IFC experiments.</p>
<p>Traditional microscopic methods have many advantages compared with IFC; they have better spatial resolution and allow analysis of spatial-temporal organization of the samples, time-lapse experiments with single cells, and so on (<xref ref-type="bibr" rid="bibr75-0022155412453052">Rimon and Schuldiner 2011</xref>). However, a limited number of cells are evaluated, and until recent introduction of automated systems, operator bias always had to be considered. IFC has common traits with high-throughput microscopic systems, such as moderate resolution (0.5–1.0 µ) and the capability of analyzing thousands of cellular events (<xref ref-type="table" rid="table1-0022155412453052">Table 1</xref>). On the other hand, high-throughput fluorescent microscopy (HTFM) has advantages of time-lapse analysis of cells and parallel analysis of hundreds of markers, and no perturbation is used for adherent cells. The major advantages of IFC include a hardware that is oriented to analysis without perturbation of cells into suspension and well-developed software that does not require programming skills and is not limited by a few prearranged analysis algorithms. The choice between the currently available microscopic imaging software is influenced mainly by the programming expertise and the hardware resources (<xref ref-type="bibr" rid="bibr82-0022155412453052">Terjung et al. 2010</xref>).</p>
<table-wrap id="table1-0022155412453052" position="float">
<label>Table 1.</label>
<caption>
<p>Summary of Imaging Flow Cytometry (IFC) and Other Common Techniques for Cell Population Analysis</p>
</caption>
<graphic alternate-form-of="table1-0022155412453052" xlink:href="10.1369_0022155412453052-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Feature</th>
<th align="center">Western Blotting</th>
<th align="center">IFC</th>
<th align="center">Flow Cytometry</th>
<th align="center">Laser Scanning Cytometry</th>
<th align="center">High-throughput Fluorescent Microscopy</th>
</tr>
</thead>
<tbody>
<tr>
<td>Capable of analyzing heterogeneous cell population</td>
<td>No</td>
<td>Yes</td>
<td>Yes</td>
<td>Yes</td>
<td>Yes</td>
</tr>
<tr>
<td>Light scatter</td>
<td>No</td>
<td>Yes (side scatter)</td>
<td>Yes (forward and side scatter)</td>
<td>Yes</td>
<td>No</td>
</tr>
<tr>
<td>Brightfield</td>
<td>No</td>
<td>Yes</td>
<td>No</td>
<td>Yes</td>
<td>Yes</td>
</tr>
<tr>
<td>Capable of analyzing rare subpopulation (&lt;0.01%)</td>
<td>No</td>
<td>Yes</td>
<td>Yes</td>
<td>Capable of analyzing 1:10<sup>4</sup> cells (<xref ref-type="bibr" rid="bibr56-0022155412453052">Megyeri et al. 2004</xref>)</td>
<td>No</td>
</tr>
<tr>
<td>Needs spectral compensation</td>
<td>NA</td>
<td>Yes</td>
<td>Yes</td>
<td>No</td>
<td>No</td>
</tr>
<tr>
<td>Cell morphology data</td>
<td>No</td>
<td>Yes</td>
<td>No</td>
<td>Yes</td>
<td>Yes</td>
</tr>
<tr>
<td>Statistics (representative experiment)</td>
<td>Averaged data from 5 × 10<sup>5</sup>–10<sup>6</sup> cells per slot</td>
<td>10<sup>3</sup>–10<sup>4</sup> events</td>
<td>Up to 10<sup>6</sup>–10<sup>7</sup> events</td>
<td>10<sup>2</sup>–10<sup>5</sup> cells</td>
<td>10<sup>2</sup>–10<sup>4</sup> cells</td>
</tr>
<tr>
<td>Speed of acquisition</td>
<td>5 × 10<sup>5</sup>–10<sup>6</sup> cells per slot up to 10<sup>1</sup>–3 × 10<sup>1</sup> slots/hr</td>
<td>300–1000 events/sec</td>
<td>3000–10,000 events/sec</td>
<td>Up to 100 cells/sec (5000 cells/min) (<xref ref-type="bibr" rid="bibr71-0022155412453052">Pozarowski et al. 2006</xref>)</td>
<td>Parallel acquisition; rate depends on the exposure time</td>
</tr>
<tr>
<td>Single-cell analysis (time lapse)</td>
<td>No</td>
<td>No</td>
<td>No</td>
<td>Yes</td>
<td>Yes</td>
</tr>
<tr>
<td>Cell population analysis (time lapse)</td>
<td>No</td>
<td>Yes</td>
<td>Yes</td>
<td>Yes</td>
<td>Yes</td>
</tr>
<tr>
<td>Operator bias</td>
<td>Not significant</td>
<td>Not significant</td>
<td>Not significant</td>
<td>Not significant</td>
<td>Not significant</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0022155412453052">
<p>NA, not applicable.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Although technical limitations continue to be addressed through constant developments, the multicolor experiments developed for flow cytometers or microscopes are not immediately transferable to IS instruments (IS-X or early model IS-100). Some differences need to be taken into account when you are planning the multicolor assays using an imaging flow cytometer. Two major considerations are the following: 1) wide bandpass of the optical filters and related significant spectral compensation and 2) optimal speed that relies on cell concentrations and is relatively low. For example, maximal speed (up to 300 events/sec for IS-100 and up to 1000 events/sec for IS-X) can only be achieved with a relatively high sample concentration that is about 10<sup>7</sup> cells per milliliter (500,000 cells per 50 µl of volume for IS-100 and 3× less for IS-X). Another problem that stems from the contamination of the sample is a large number of non-target fluorescent particles and microparticles, which are acquired by IS systems as separate events.</p>
<p>The acquisition timescale in IFC ranges in minutes, all the way from tenths of a minute to 100 min needed to push through tens of thousands of events from samples with a low cellular concentration. Several issues arise when trying to automatically image multiple live cells with the help of the IS series in IFC, such as the lack of availability of nutrients and oxygen over long time periods, because samples presumably are run in phosphate buffer solution (PBS). Focusing is a large contributor to the length of time required for analysis, because a large percentage of cells will be excluded from analysis due to focusing problems. Moreover, if fluorescence labeling with cell tracking and vital dyes is used, additional experiments are required to exclude phototoxicity as a reason for observed differences between the experimental and control cells.</p>
<p>Postacquisition image analysis of data from IS instruments requires pixel-by-pixel spectral compensation, described in detail in the study published by <xref ref-type="bibr" rid="bibr62-0022155412453052">Ortyn et al. (2006)</xref>. The IS instruments have wide, non-interchangeable optical filters with the width in ranges from 25 to 85 nm (channel 3, 500–560 nm; channel 4, 560–595 nm; channel 5, 595–660 nm; channel 6, 660–730 nm for IS-100) (see Suppl. Table S1 for IS-X). Many dyes may require a significant spectral compensation (e.g., dihydroethidium [DHE] may require 73.9% compensation in channel 4 and 40.6% compensation with DRAQ 5; cited by <xref ref-type="bibr" rid="bibr69-0022155412453052">Ploppa et al. 2011</xref> for the IS-100). This leads to the low detection signal of quantum dots (QDs) and such standard violet dyes as Pacific Blue and Pacific Orange. These dyes are practically undetectable in the multiparameter panels partly due to the significant spectral compensation (<xref ref-type="bibr" rid="bibr13-0022155412453052">Chattopadhyay et al. 2012</xref>; our unpublished data). The preferential violet fluorochromes for antibody conjugates imaged with IS instruments are Brilliant Violet–based tandem dyes (<xref ref-type="bibr" rid="bibr13-0022155412453052">Chattopadhyay et al. 2012</xref>). The QD combinations for IS instruments provide a good staining only in the absence in the panel overlapping bright fluorochromes with wide spectra; that is, only as a combination of different QDs together (such as QD525 and QD605 in the study by <xref ref-type="bibr" rid="bibr21-0022155412453052">Domhan et al. 2011</xref>).</p>
<p>It is useful to perform IFC in combination with other methodologies (Western blotting, FC, fluorescent microscopy) and verify, if the different platforms can give comparable results. Consequently, it will help to overcome drawbacks and ambiguities associated with data interpretation.</p>
</sec>
<sec id="section6-0022155412453052">
<title>Conclusions</title>
<p>Recent advances in fluorescent technologies have made the collection of multiparametric imaging files routine, but efficient analysis of these data remains a challenge. IFC offers a solution by allowing a collection of tens of thousands of cellular events and the choice of gated statistical analysis on the basis of fluorescent and morphological features combined with the capability of identifying collected objects on the basis of real images. The principal enhancements of IFC over the past 5 years have been the following: 1) the introduction of a higher resolution (60× objective); 2) using variable objectives, allowing the throughput options to be tailored to the requirements of a specific application (the speed of acquisition can be increased up to 1000 events/sec); 3) introducing additional functionality to the instrumentation (switching between FC and IFC modes); and 4) increasing laser line versatility (to enhance reagent compatibility and multiplexing capability). The advantage of IFC compared with high-throughput microscopy and laser scanning cytometry systems designed to work with adherent cells is its well-developed experiment-approached software and its ability to image cells in suspension. Thus, IFC takes its own unique place in biomedical research. Also, as the interest in performing IFC systems grows, the necessity of combining this technique with cell sorting becomes evident.</p>
</sec>
</body>
<back>
<ack><p>We are grateful to Aleksandra Gorelova for help with the preparation of the manuscript. Space considerations limited us to a selected list of available literature on IFC.</p></ack>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work was supported in part by NIH S10 RR023459 grant and the Immune Disease Institute to NSB and RFBR grant 11-04-01749a to IAV.</p>
</fn>
<fn fn-type="supplementary-material">
<p>Supplementary material for this article is available on the <italic>Journal of Histochemistry &amp; Cytochemistry</italic> Web site at <ext-link ext-link-type="uri" xlink:href="http://jhc.sagepub.com/supplemental">http://jhc.sagepub.com/supplemental</ext-link>.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ahmed</surname><given-names>F</given-names></name>
<name><surname>Friend</surname><given-names>S</given-names></name>
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Barteneva</surname><given-names>N</given-names></name>
<name><surname>Lieberman</surname><given-names>J</given-names></name>
</person-group>. <year>2009</year>. <article-title>Numbers matter: quantitative and dynamic analysis of the formation of an immunological synapse</article-title>. <source>J Immunol Methods</source>. <volume>347</volume>:<fpage>79</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr2-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alberti</surname><given-names>DS</given-names></name>
<name><surname>Angeloni</surname><given-names>G</given-names></name>
<name><surname>Tamburelli</surname><given-names>C</given-names></name>
<name><surname>Pampuch</surname><given-names>A</given-names></name>
<name><surname>Izzsi</surname><given-names>B</given-names></name>
<name><surname>Messano</surname><given-names>L</given-names></name>
<name><surname>Parisi</surname><given-names>Q</given-names></name>
<name><surname>Santamaria</surname><given-names>M</given-names></name>
<name><surname>Donati</surname><given-names>MB</given-names></name>
<name><surname>de Gaetano</surname><given-names>G</given-names></name><etal/>
</person-group>. <year>2009</year>. <article-title>Platelet-leukocyte mixed conjugates in patients with atrial fibrillation</article-title>. <source>Platelets</source>. <volume>20</volume>:<fpage>235</fpage>–<lpage>241</lpage>.</citation>
</ref>
<ref id="bibr3-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ansari</surname><given-names>B</given-names></name>
<name><surname>Coates</surname><given-names>PJ</given-names></name>
<name><surname>Greenstein</surname><given-names>BD</given-names></name>
<name><surname>Hall</surname><given-names>PA</given-names></name>
</person-group>. <year>1993</year>. <article-title>In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states</article-title>. <source>J Pathol</source>. <volume>170</volume>:<fpage>1</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr4-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arechiga</surname><given-names>AF</given-names></name>
<name><surname>Bell</surname><given-names>BD</given-names></name>
<name><surname>Solomon</surname><given-names>JC</given-names></name>
<name><surname>Chu</surname><given-names>IH</given-names></name>
<name><surname>Dubois</surname><given-names>CL</given-names></name>
<name><surname>Hall</surname><given-names>BE</given-names></name>
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Coder</surname><given-names>DM</given-names></name>
<name><surname>Walsh</surname><given-names>CM</given-names></name>
</person-group>. <year>2005</year>. <article-title>Cutting edge: FADD is not required for antigen receptor-mediated NF-kappaB activation</article-title>. <source>J Immunol</source>. <volume>175</volume>:<fpage>7800</fpage>–<lpage>7804</lpage>.</citation>
</ref>
<ref id="bibr5-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Armstrong</surname><given-names>L</given-names></name>
<name><surname>Hughes</surname><given-names>O</given-names></name>
<name><surname>Yung</surname><given-names>S</given-names></name>
<name><surname>Hyslop</surname><given-names>L</given-names></name>
<name><surname>Stewart</surname><given-names>R</given-names></name>
<name><surname>Wappler</surname><given-names>I</given-names></name>
<name><surname>Peters</surname><given-names>H</given-names></name>
<name><surname>Walter</surname><given-names>T</given-names></name>
<name><surname>Stojkovic</surname><given-names>P</given-names></name>
<name><surname>Evans</surname><given-names>J</given-names></name><etal/>
</person-group>. <year>2006</year>. <article-title>The role of PI3K/AKT, MAPK/ERK and NFkappaB signaling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis</article-title>. <source>Hum Mol Genet</source>. <volume>15</volume>:<fpage>1894</fpage>–<lpage>1913</lpage>.</citation>
</ref>
<ref id="bibr6-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Basiji</surname><given-names>DA</given-names></name>
<name><surname>Ortyn</surname><given-names>WE</given-names></name>
<name><surname>Liang</surname><given-names>L</given-names></name>
<name><surname>Venkatachalam</surname><given-names>V</given-names></name>
<name><surname>Morrissey</surname><given-names>P</given-names></name>
</person-group>. <year>2007</year>. <article-title>Cellular image analysis and imaging by flow cytometry</article-title>. <source>Clin Lab Med</source>. <volume>27</volume>:<fpage>653</fpage>–<lpage>670</lpage>.</citation>
</ref>
<ref id="bibr7-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bedner</surname><given-names>E</given-names></name>
<name><surname>Burfeind</surname><given-names>P</given-names></name>
<name><surname>Hsieh</surname><given-names>TC</given-names></name>
<name><surname>Wu</surname><given-names>JM</given-names></name>
<name><surname>Aguero-Rosenfeld</surname><given-names>ME</given-names></name>
<name><surname>Melamed</surname><given-names>MR</given-names></name>
<name><surname>Horowitz</surname><given-names>HW</given-names></name>
<name><surname>Wormser</surname><given-names>GP</given-names></name>
<name><surname>Darzynkiewicz</surname><given-names>Z</given-names></name>
</person-group>. <year>1998</year>. <article-title>Cell cycle effects and induction of apoptosis caused by infection of HL-60 cells with human granulocytic ehrlichiosis pathogen measured by flow and laser scanning cytometry</article-title>. <source>Cytometry</source>. <volume>33</volume>:<fpage>47</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr8-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bedner</surname><given-names>E</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Gorczyca</surname><given-names>W</given-names></name>
<name><surname>Melamed</surname><given-names>MR</given-names></name>
</person-group>. <year>1999</year>. <article-title>Analysis of apoptosis by laser scanning cytometry</article-title>. <source>Cytometry</source>. <volume>35</volume>:<fpage>181</fpage>–<lpage>195</lpage>.</citation>
</ref>
<ref id="bibr9-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bisha</surname><given-names>B</given-names></name>
<name><surname>Brehm-Stecher</surname><given-names>BF</given-names></name>
</person-group>. <year>2009</year>. <article-title>Flow-through imaging cytometry for characterization of <italic>Salmonella</italic> subpopulations in alfalfa sprouts, a complex food system</article-title>. <source>Biotechnology J</source>. <volume>4</volume>:<fpage>880</fpage>–<lpage>887</lpage>.</citation>
</ref>
<ref id="bibr10-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brennan</surname><given-names>DJO</given-names></name>
<name><surname>Connor</surname><given-names>DP</given-names></name>
<name><surname>Rexhepaj</surname><given-names>E</given-names></name>
<name><surname>Ponten</surname><given-names>F</given-names></name>
<name><surname>Gallaqher</surname><given-names>WM</given-names></name>
</person-group>. <year>2010</year>. <article-title>Antibody-based proteomics: fast-tracking molecular diagnostics in oncology</article-title>. <source>Nat Rev Cancer</source>. <volume>10</volume>:<fpage>605</fpage>–<lpage>617</lpage>.</citation>
</ref>
<ref id="bibr11-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bucur</surname><given-names>O</given-names></name>
<name><surname>Stancu</surname><given-names>AL</given-names></name>
<name><surname>Khosravi-Far</surname><given-names>R</given-names></name>
<name><surname>Almasan</surname><given-names>A</given-names></name>
</person-group>. <year>2012</year>. <article-title>Analysis of apoptosis methods recently used in Cancer Research and Cell Death &amp; Disease publications</article-title>. <source>Cell Death Disease</source>. <volume>3</volume>:<fpage>e263</fpage>.</citation>
</ref>
<ref id="bibr12-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>HH</given-names></name>
<name><surname>Hemberg</surname><given-names>M</given-names></name>
<name><surname>Barahona</surname><given-names>M</given-names></name>
<name><surname>Ingber</surname><given-names>DE</given-names></name>
<name><surname>Huang</surname><given-names>S</given-names></name>
</person-group>. <year>2008</year>. <article-title>Transcriptome-wide noise controls lineage choice in mammalian progenitor cells</article-title>. <source>Nature</source>. <volume>453</volume>:<fpage>544</fpage>–<lpage>547</lpage>.</citation>
</ref>
<ref id="bibr13-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chattopadhyay</surname><given-names>PK</given-names></name>
<name><surname>Gaylord</surname><given-names>B</given-names></name>
<name><surname>Palmer</surname><given-names>A</given-names></name>
<name><surname>Jiang</surname><given-names>N</given-names></name>
<name><surname>Raven</surname><given-names>MA</given-names></name>
<name><surname>Lewis</surname><given-names>G</given-names></name>
<name><surname>Reuter</surname><given-names>MA</given-names></name>
<name><surname>Nur-Ur Rahman</surname><given-names>AK</given-names></name>
<name><surname>Price</surname><given-names>DA</given-names></name>
<name><surname>Betts</surname><given-names>MR</given-names></name><etal/>
</person-group>. <year>2012</year>. <article-title>Brilliant violet fluorophores: a new class of ultrabright fluorescent compounds for immunofluorescence experiments</article-title>. <source>Cytometry</source>. <volume>81</volume>:<fpage>456</fpage>–<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr14-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crisman</surname><given-names>TJ</given-names></name>
<name><surname>Parker</surname><given-names>CN</given-names></name>
<name><surname>Jenkins</surname><given-names>JL</given-names></name>
<name><surname>Scheiber</surname><given-names>J</given-names></name>
<name><surname>Thoma</surname><given-names>M</given-names></name>
<name><surname>Kang</surname><given-names>ZB</given-names></name>
<name><surname>Kim</surname><given-names>R</given-names></name>
<name><surname>Bender</surname><given-names>A</given-names></name>
<name><surname>Nettles</surname><given-names>JH</given-names></name>
<name><surname>Davies</surname><given-names>JW</given-names></name><etal/>
</person-group>. <year>2007</year>. <article-title>Understanding false positives in reporter gene assays: in silico chemogenomics approaches to prioritize cell-based HTS data</article-title>. <source>J Chem Inf Model</source>. <volume>47</volume>:<fpage>1319</fpage>–<lpage>1327</lpage>.</citation>
</ref>
<ref id="bibr15-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Danis</surname><given-names>B</given-names></name>
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Goriely</surname><given-names>S</given-names></name>
<name><surname>Dutta</surname><given-names>B</given-names></name>
<name><surname>Renneson</surname><given-names>J</given-names></name>
<name><surname>Gatto</surname><given-names>L</given-names></name>
<name><surname>Fitzgerald-Bocarsly</surname><given-names>P</given-names></name>
<name><surname>Marchant</surname><given-names>A</given-names></name>
<name><surname>Goldman</surname><given-names>M</given-names></name>
<name><surname>Willems</surname><given-names>F</given-names></name><etal/>
</person-group>. <year>2008</year>. <article-title>Interferon regulatory factor-7 mediated responses are defective in cord blood plasmacytoid dendritic cells</article-title>. <source>Eur J Immunol</source>. <volume>38</volume>:<fpage>507</fpage>–<lpage>517</lpage>.</citation>
</ref>
<ref id="bibr16-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Darzynkiewicz</surname><given-names>Z</given-names></name>
<name><surname>Bedner</surname><given-names>E</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Gorczyca</surname><given-names>W</given-names></name>
<name><surname>Melamed</surname><given-names>MR</given-names></name>
</person-group>. <year>1999</year>. <article-title>Laser-scanning cytometry: a new instrumentation with many applications</article-title>. <source>Exp Cell Res</source>. <volume>249</volume>:<fpage>1</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr17-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Darzynkiewicz</surname><given-names>Z</given-names></name>
<name><surname>Bedner</surname><given-names>E</given-names></name>
<name><surname>Traganos</surname><given-names>F</given-names></name>
</person-group>. <year>2001</year>. <article-title>Difficulties and pitfalls in analysis of apoptosis</article-title>. <source>Methods Cell Biol</source>. <volume>63</volume>:<fpage>527</fpage>–<lpage>546</lpage>.</citation>
</ref>
<ref id="bibr18-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De la Calle</surname><given-names>C</given-names></name>
<name><surname>Joubert</surname><given-names>P-E</given-names></name>
<name><surname>Law</surname><given-names>HKW</given-names></name>
<name><surname>Hasan</surname><given-names>M</given-names></name>
<name><surname>Albert</surname><given-names>ML</given-names></name>
</person-group>. <year>2011</year>. <article-title>Simultaneous assessment of autophagy and apoptosis using multispectral imaging cytometry</article-title>. <source>Autophagy</source>. <volume>7</volume>:<fpage>1045</fpage>–<lpage>1051</lpage>.</citation>
</ref>
<ref id="bibr19-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dietmair</surname><given-names>S</given-names></name>
<name><surname>Nielsen</surname><given-names>LK</given-names></name>
<name><surname>Timmins</surname><given-names>NE</given-names></name>
</person-group>. <year>2012</year>. <article-title>Mammalian cells as biopharmaceutical production hosts in the age of omics</article-title>. <source>Biotechnology J</source>. <volume>7</volume>:<fpage>75</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr20-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ding</surname><given-names>GJ</given-names></name>
<name><surname>Fischer</surname><given-names>PA</given-names></name>
<name><surname>Boltz</surname><given-names>RC</given-names></name>
<name><surname>Schmidt</surname><given-names>JA</given-names></name>
<name><surname>Colainne</surname><given-names>JJ</given-names></name>
<name><surname>Cough</surname><given-names>A</given-names></name>
<name><surname>Rubin</surname><given-names>RA</given-names></name>
<name><surname>Miller</surname><given-names>DK</given-names></name>
</person-group>. <year>1998</year>. <article-title>Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha: development and use of a high capacity fluorescence cytometric system</article-title>. <source>J Biol Chem</source>. <volume>273</volume>:<fpage>28897</fpage>–<lpage>28905</lpage>.</citation>
</ref>
<ref id="bibr21-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Domhan</surname><given-names>S</given-names></name>
<name><surname>Ma</surname><given-names>L</given-names></name>
<name><surname>Tai</surname><given-names>A</given-names></name>
<name><surname>Anaya</surname><given-names>Z</given-names></name>
<name><surname>Beheshti</surname><given-names>A</given-names></name>
<name><surname>Zeier</surname><given-names>M</given-names></name>
<name><surname>Hlatky</surname><given-names>L</given-names></name>
<name><surname>Abdollahi</surname><given-names>A</given-names></name>
</person-group>. <year>2011</year>. <article-title>Intercellular communication by exchange of cytoplasmic material via tunelling nano-tube like structures in primary human renal epithelial cells</article-title>. <source>PLoS One</source>. <volume>6</volume>:<fpage>e21283</fpage>.</citation>
</ref>
<ref id="bibr22-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elowitz</surname><given-names>MB</given-names></name>
<name><surname>Levine</surname><given-names>AJ</given-names></name>
<name><surname>Siggia</surname><given-names>ED</given-names></name>
<name><surname>Swain</surname><given-names>PS</given-names></name>
</person-group>. <year>2002</year>. <article-title>Stochastic gene expression in a single cell</article-title>. <source>Science</source>. <volume>297</volume>:<fpage>1183</fpage>–<lpage>1186</lpage>.</citation>
</ref>
<ref id="bibr23-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fanning</surname><given-names>SL</given-names></name>
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Feng</surname><given-names>D</given-names></name>
<name><surname>Feldman</surname><given-names>SB</given-names></name>
<name><surname>Megjiugorac</surname><given-names>NJ</given-names></name>
<name><surname>Isaguirre</surname><given-names>AG</given-names></name>
<name><surname>Fitzgerald-Bocarsly</surname><given-names>P</given-names></name>
</person-group>. <year>2006</year>. <article-title>Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-gamma production</article-title>. <source>J Immunol</source>. <volume>177</volume>:<fpage>5829</fpage>–<lpage>5839</lpage>.</citation>
</ref>
<ref id="bibr24-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Filby</surname><given-names>A</given-names></name>
<name><surname>Perucha</surname><given-names>E</given-names></name>
<name><surname>Summers</surname><given-names>H</given-names></name>
<name><surname>Rees</surname><given-names>P</given-names></name>
<name><surname>Chana</surname><given-names>P</given-names></name>
<name><surname>Heck</surname><given-names>S</given-names></name>
<name><surname>Lord</surname><given-names>GM</given-names></name>
<name><surname>Davies</surname><given-names>D</given-names></name>
</person-group>. <year>2011</year>. <article-title>An imaging flow cytometric method for measuring cell division history and molecular symmetry during mitosis</article-title>. <source>Cytometry A</source>. <volume>79</volume>:<fpage>496</fpage>–<lpage>506</lpage>.</citation>
</ref>
<ref id="bibr25-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frankfurt</surname><given-names>OS</given-names></name>
<name><surname>Robb</surname><given-names>JA</given-names></name>
<name><surname>Sugarbaker</surname><given-names>EV</given-names></name>
<name><surname>Villa</surname><given-names>L</given-names></name>
</person-group>. <year>1996</year>. <article-title>Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis</article-title>. <source>Exp Cell Res</source>. <volume>226</volume>:<fpage>387</fpage>–<lpage>397</lpage>.</citation>
</ref>
<ref id="bibr26-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Basiji</surname><given-names>DA</given-names></name>
<name><surname>Hall</surname><given-names>BE</given-names></name>
<name><surname>Lynch</surname><given-names>DH</given-names></name>
<name><surname>Ortyn</surname><given-names>WE</given-names></name>
<name><surname>Perry</surname><given-names>DJ</given-names></name>
<name><surname>Seo</surname><given-names>MJ</given-names></name>
<name><surname>Zimmerman</surname><given-names>CA</given-names></name>
<name><surname>Morrissey</surname><given-names>PJ</given-names></name>
</person-group>. <year>2004</year>. <article-title>Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer</article-title>. <source>Cytometry A</source>. <volume>59</volume>:<fpage>237</fpage>–<lpage>245</lpage>.</citation>
</ref>
<ref id="bibr27-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Fanning</surname><given-names>SL</given-names></name>
<name><surname>Fitzgerald-Bocarsly</surname><given-names>P</given-names></name>
<name><surname>Medeiros</surname><given-names>RB</given-names></name>
<name><surname>Highfill</surname><given-names>S</given-names></name>
<name><surname>Shimizu</surname><given-names>Y</given-names></name>
<name><surname>Hall</surname><given-names>BE</given-names></name>
<name><surname>Frost</surname><given-names>K</given-names></name>
<name><surname>Basiji</surname><given-names>D</given-names></name>
<name><surname>Ortyn</surname><given-names>WE</given-names></name><etal/>
</person-group>. <year>2006</year>. <article-title>Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow</article-title>. <source>J Immunol Methods</source>. <volume>311</volume>:<fpage>117</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr28-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gerstner</surname><given-names>AO</given-names></name>
<name><surname>Trumpfheller</surname><given-names>C</given-names></name>
<name><surname>Racz</surname><given-names>P</given-names></name>
<name><surname>Osmancik</surname><given-names>P</given-names></name>
<name><surname>Tenner-Racz</surname><given-names>K</given-names></name>
<name><surname>Tarnok</surname><given-names>A</given-names></name>
</person-group>. <year>2004</year>. <article-title>Quantitative histology by multicolor slide-based cytometry</article-title>. <source>Cytometry A</source>. <volume>59</volume>:<fpage>210</fpage>–<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr29-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goetz</surname><given-names>AK</given-names></name>
<name><surname>Zahler</surname><given-names>S</given-names></name>
<name><surname>Stumpf</surname><given-names>P</given-names></name>
<name><surname>Welsch</surname><given-names>U</given-names></name>
<name><surname>Becker</surname><given-names>BF</given-names></name>
</person-group>. <year>2005</year>. <article-title>Intracoronary formation and retention of micro aggregates of leukocytes and platelets contribute to postischemic myocardial dysfunction</article-title>. <source>Basic Res Cardiol</source>. <volume>100</volume>:<fpage>413</fpage>–<lpage>421</lpage>.</citation>
</ref>
<ref id="bibr30-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harding</surname><given-names>SA</given-names></name>
<name><surname>Din</surname><given-names>JN</given-names></name>
<name><surname>Sarma</surname><given-names>J</given-names></name>
<name><surname>Jessop</surname><given-names>A</given-names></name>
<name><surname>Weatherall</surname><given-names>M</given-names></name>
<name><surname>Fox</surname><given-names>KAA</given-names></name>
<name><surname>Newby</surname><given-names>DE</given-names></name>
</person-group>. <year>2007</year>. <article-title>Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations</article-title>. <source>Thromb Hemostasis</source>. <volume>98</volume>:<fpage>451</fpage>–<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr31-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heller</surname><given-names>PG</given-names></name>
<name><surname>Lev</surname><given-names>PR</given-names></name>
<name><surname>Salim</surname><given-names>JP</given-names></name>
<name><surname>Kornblihtt</surname><given-names>LI</given-names></name>
<name><surname>Goette</surname><given-names>NP</given-names></name>
<name><surname>Chazaretta</surname><given-names>CD</given-names></name>
<name><surname>Glembotsky</surname><given-names>AS</given-names></name>
<name><surname>Vassallu</surname><given-names>PS</given-names></name>
<name><surname>Marta</surname><given-names>RF</given-names></name>
<name><surname>Molinas</surname><given-names>FC</given-names></name>
</person-group>. <year>2006</year>. <article-title>JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status</article-title>. <source>Eur J Haematol</source>. <volume>77</volume>:<fpage>210</fpage>–<lpage>216</lpage>.</citation>
</ref>
<ref id="bibr32-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Henery</surname><given-names>S</given-names></name>
<name><surname>George</surname><given-names>T</given-names></name>
<name><surname>Hall</surname><given-names>B</given-names></name>
<name><surname>Basiji</surname><given-names>D</given-names></name>
<name><surname>Ortyn</surname><given-names>W</given-names></name>
<name><surname>Morrissey</surname><given-names>P</given-names></name>
</person-group>. <year>2008</year>. <article-title>Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods</article-title>. <source>Apoptosis</source>. <volume>13</volume>:<fpage>1054</fpage>–<lpage>1063</lpage>.</citation>
</ref>
<ref id="bibr33-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Henriksen</surname><given-names>M</given-names></name>
<name><surname>Miller</surname><given-names>B</given-names></name>
<name><surname>Newmark</surname><given-names>J</given-names></name>
<name><surname>Al-Kofahi</surname><given-names>Y</given-names></name>
<name><surname>Holden</surname><given-names>E</given-names></name>
</person-group>. <year>2011</year>. <article-title>Laser scanning cytometry and its applications: a pioneering technology in the field of quantitative imaging cytometry</article-title>. <source>Methods Cell Biol</source>. <volume>102</volume>:<fpage>161</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr34-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>B</given-names></name>
<name><surname>Bates</surname><given-names>M</given-names></name>
<name><surname>Zhuang</surname><given-names>X</given-names></name>
</person-group>. <year>2009</year>. <article-title>Super-resolution fluorescence microscopy</article-title>. <source>Annu Rev Biochem</source>. <volume>78</volume>:<fpage>993</fpage>–<lpage>1016</lpage>.</citation>
</ref>
<ref id="bibr35-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>S</given-names></name>
</person-group>. <year>2009</year>. <article-title>Non-genetic heterogeneity of cells in development: more than just a noise</article-title>. <source>Development</source>. <volume>136</volume>:<fpage>3853</fpage>–<lpage>3862</lpage>.</citation>
</ref>
<ref id="bibr36-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Izzi</surname><given-names>B</given-names></name>
<name><surname>Pampuch</surname><given-names>A</given-names></name>
<name><surname>Costanzo</surname><given-names>S</given-names></name>
<name><surname>Vohnout</surname><given-names>B</given-names></name>
<name><surname>Iacoviello</surname><given-names>L</given-names></name>
<name><surname>Cerletti</surname><given-names>C</given-names></name>
<name><surname>de Gaetano</surname><given-names>G</given-names></name>
</person-group>. <year>2007</year>. <article-title>Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood</article-title>. <source>Thromb Haemost</source>. <volume>98</volume>:<fpage>1276</fpage>–<lpage>1284</lpage>.</citation>
</ref>
<ref id="bibr37-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaern</surname><given-names>M</given-names></name>
<name><surname>Elston</surname><given-names>T</given-names></name>
<name><surname>Blake</surname><given-names>W</given-names></name>
<name><surname>Collins</surname><given-names>J</given-names></name>
</person-group>. <year>2005</year>. <article-title>Stochasticity in gene expression: from theories to phenotypes</article-title>. <source>Nat Rev Genet</source>. <volume>6</volume>:<fpage>451</fpage>–<lpage>464</lpage>.</citation>
</ref>
<ref id="bibr38-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kamentsky</surname><given-names>LA</given-names></name>
<name><surname>Kamentsky</surname><given-names>LD</given-names></name>
</person-group>. <year>1991</year>. <article-title>Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data</article-title>. <source>Cytometry</source>. <volume>12</volume>:<fpage>381</fpage>–<lpage>387</lpage>.</citation>
</ref>
<ref id="bibr39-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khuda</surname><given-names>SE</given-names></name>
<name><surname>Loo</surname><given-names>WM</given-names></name>
<name><surname>Janz</surname><given-names>S</given-names></name>
<name><surname>Van Ness</surname><given-names>B</given-names></name>
<name><surname>Erickson</surname><given-names>LD</given-names></name>
</person-group>. <year>2008</year>. <article-title>Deregulation of c-Myc confers distinct survival requirements for memory B cells, plasma cells, and their progenitors</article-title>. <source>J Immunol</source>. <volume>181</volume>:<fpage>7537</fpage>–<lpage>7549</lpage>.</citation>
</ref>
<ref id="bibr40-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>NS</given-names></name>
<name><surname>Kim</surname><given-names>SJ</given-names></name>
<name><surname>Lee</surname><given-names>GM</given-names></name>
</person-group>. <year>1998</year>. <article-title>Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure</article-title>. <source>Biotechnol Bioeng</source>. <volume>60</volume>:<fpage>679</fpage>–<lpage>688</lpage>.</citation>
</ref>
<ref id="bibr41-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knijnenburg</surname><given-names>TA</given-names></name>
<name><surname>Roda</surname><given-names>O</given-names></name>
<name><surname>Wan</surname><given-names>Y</given-names></name>
<name><surname>Nolan</surname><given-names>GP</given-names></name>
<name><surname>Aitchison</surname><given-names>JD</given-names></name>
<name><surname>Shmulevich</surname><given-names>I</given-names></name>
</person-group>. <year>2011</year>. <article-title>A regression model approach to enable cell morphology correction in high-throughput flow cytometry</article-title>. <source>Mol Syst Biol</source>. <volume>7</volume>:<fpage>531</fpage>.</citation>
</ref>
<ref id="bibr42-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kornblau</surname><given-names>SM</given-names></name>
<name><surname>Tibes</surname><given-names>R</given-names></name>
<name><surname>Qui</surname><given-names>YH</given-names></name>
<name><surname>Chen</surname><given-names>W</given-names></name>
<name><surname>Kantarjian</surname><given-names>HM</given-names></name>
<name><surname>Andreeff</surname><given-names>M</given-names></name>
<name><surname>Coombes</surname><given-names>KR</given-names></name>
<name><surname>Mills</surname><given-names>GB</given-names></name>
</person-group>. <year>2009</year>. <article-title>Functional proteomic profiling of AML predicts response and survival</article-title>. <source>Blood</source>. <volume>113</volume>:<fpage>154</fpage>–<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr43-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kotecha</surname><given-names>N</given-names></name>
<name><surname>Flores</surname><given-names>NJ</given-names></name>
<name><surname>Irish</surname><given-names>JM</given-names></name>
<name><surname>Simonds</surname><given-names>EF</given-names></name>
<name><surname>Sakai</surname><given-names>DS</given-names></name>
<name><surname>Archambeault</surname><given-names>S</given-names></name>
<name><surname>Diaqz-Flores</surname><given-names>S</given-names></name>
<name><surname>Coram</surname><given-names>M</given-names></name>
<name><surname>Shannon</surname><given-names>KM</given-names></name>
<name><surname>Nolan</surname><given-names>GP</given-names></name><etal/>
</person-group>. <year>2008</year>. <article-title>Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates</article-title>. <source>Cancer Cell</source>. <volume>14</volume>:<fpage>335</fpage>–<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr44-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krutzik</surname><given-names>PO</given-names></name>
<name><surname>Irish</surname><given-names>JM</given-names></name>
<name><surname>Nolan</surname><given-names>GP</given-names></name>
<name><surname>Perez</surname><given-names>OD</given-names></name>
</person-group>. <year>2004</year>. <article-title>Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications</article-title>. <source>Clin Immunol</source>. <volume>110</volume>:<fpage>206</fpage>–<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr45-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krutzik</surname><given-names>PO</given-names></name>
<name><surname>Nolan</surname><given-names>GP</given-names></name>
</person-group>. <year>2003</year>. <article-title>Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events</article-title>. <source>Cytometry A</source>. <volume>55</volume>:<fpage>61</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr46-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krutzik</surname><given-names>PO</given-names></name>
<name><surname>Trejo</surname><given-names>A</given-names></name>
<name><surname>Schulz</surname><given-names>KR</given-names></name>
<name><surname>Nolan</surname><given-names>GP</given-names></name>
</person-group>. <year>2011</year>. <article-title>Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood cells</article-title>. <source>Methods Mol Biol</source>. <volume>699</volume>:<fpage>179</fpage>–<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr47-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kucia</surname><given-names>M</given-names></name>
<name><surname>Reca</surname><given-names>R</given-names></name>
<name><surname>Campbell</surname><given-names>FR</given-names></name>
<name><surname>Zuba-Surma</surname><given-names>E</given-names></name>
<name><surname>Majka</surname><given-names>M</given-names></name>
<name><surname>Ratajczak</surname><given-names>J</given-names></name>
<name><surname>Ratajczak</surname><given-names>MJ</given-names></name>
</person-group>. <year>2006</year>. <article-title>A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct4+ stem cells identified in adult bone marrow</article-title>. <source>Leukemia</source>. <volume>20</volume>:<fpage>857</fpage>–<lpage>869</lpage>.</citation>
</ref>
<ref id="bibr48-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuonen</surname><given-names>F</given-names></name>
<name><surname>Touvrey</surname><given-names>C</given-names></name>
<name><surname>Laurent</surname><given-names>J</given-names></name>
<name><surname>Ruegg</surname><given-names>C</given-names></name>
</person-group>. <year>2010</year>. <article-title>Fc block treatment, dead cells exclusion, and cell aggregates discrimination concur to prevent phenotypical artifacts in the analysis of subpopulations of tumor-infiltrating CD11b(+) myelomonocytic cells</article-title>. <source>Cytometry A</source>. <volume>77</volume>:<fpage>1082</fpage>–<lpage>1090</lpage>.</citation>
</ref>
<ref id="bibr49-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lambert</surname><given-names>C</given-names></name>
<name><surname>Desbarats</surname><given-names>J</given-names></name>
</person-group>. <year>2007</year>. <article-title>The anti-Fas antibody M-20 cross-reacts with intracellular proteins: implications for false-positive detection of Fas</article-title>. <source>Apoptosis</source>. <volume>12</volume>:<fpage>459</fpage>–<lpage>462</lpage>.</citation>
</ref>
<ref id="bibr50-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>AW</given-names></name>
<name><surname>Sharp</surname><given-names>ER</given-names></name>
<name><surname>O’Mahony</surname><given-names>A</given-names></name>
<name><surname>Rosenberg</surname><given-names>DM</given-names></name>
<name><surname>Israelski</surname><given-names>DM</given-names></name>
<name><surname>Nolan</surname><given-names>GP</given-names></name>
<name><surname>Dixon</surname><given-names>DF</given-names></name>
</person-group>. <year>2008</year>. <article-title>Single-cell, phosphoepitope-specific analysis demonstrates cell-type and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection</article-title>. <source>J Virol</source>. <volume>82</volume>:<fpage>3702</fpage>–<lpage>3712</lpage>.</citation>
</ref>
<ref id="bibr51-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>V</given-names></name>
<name><surname>Sharov</surname><given-names>VG</given-names></name>
<name><surname>Jiang</surname><given-names>N</given-names></name>
<name><surname>Zaloga</surname><given-names>C</given-names></name>
<name><surname>Chopp</surname><given-names>M</given-names></name>
</person-group>. <year>1995</year>. <article-title>Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat</article-title>. <source>Am J Pathol</source>. <volume>146</volume>:<fpage>1045</fpage>–<lpage>1051</lpage>.</citation>
</ref>
<ref id="bibr52-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lloyd</surname><given-names>D</given-names></name>
<name><surname>Holmes</surname><given-names>P</given-names></name>
<name><surname>Jackson</surname><given-names>L</given-names></name>
<name><surname>Emery</surname><given-names>A</given-names></name>
<name><surname>Al-Rubeai</surname><given-names>M</given-names></name>
</person-group>. <year>2000</year>. <article-title>Relationship between cell size, cell cycle and specific recombinant protein productivity</article-title>. <source>Cytotechnology</source>. <volume>34</volume>:<fpage>59</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr53-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname><given-names>C</given-names></name>
<name><surname>King</surname><given-names>RD</given-names></name>
</person-group>. <year>2009</year>. <article-title>An investigation into the population abundance distribution of mRNAs, proteins, and metabolites in biological systems</article-title>. <source>Bioinformatics</source>. <volume>25</volume>:<fpage>2020</fpage>–<lpage>2027</lpage>.</citation>
</ref>
<ref id="bibr54-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McGrath</surname><given-names>KE</given-names></name>
<name><surname>Bushnell</surname><given-names>T</given-names></name>
<name><surname>Palis</surname><given-names>J</given-names></name>
</person-group>. <year>2008</year>. <article-title>Multispectral imaging of hematopoietic cells: where flow meets morphology</article-title>. <source>J Immunol Methods</source>. <volume>336</volume>:<fpage>91</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr55-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maguire</surname><given-names>O</given-names></name>
<name><surname>Collins</surname><given-names>C</given-names></name>
<name><surname>O’Loughlin</surname><given-names>K</given-names></name>
<name><surname>Miecznikowski</surname><given-names>J</given-names></name>
<name><surname>Minderman</surname><given-names>H</given-names></name>
</person-group>. <year>2011</year>. <article-title>Quantifying nuclear p65 as a parameter for NF-κB activation: correlation between Imagestream cytometry, microscopy, and Western blot</article-title>. <source>Cytometry A</source>. <volume>79</volume>:<fpage>461</fpage>–<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr56-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Megyeri</surname><given-names>A</given-names></name>
<name><surname>Kaplan</surname><given-names>J</given-names></name>
<name><surname>Eliason</surname><given-names>JF</given-names></name>
</person-group>. <year>2004</year>. <article-title>Laser scanning cytometry for selection of green fluorescent protein transgenic mice using small number of blood cells</article-title>. <source>J Biochem Biophys Methods</source>. <volume>61</volume>:<fpage>183</fpage>–<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr57-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muskavitch</surname><given-names>MA</given-names></name>
<name><surname>Barteneva</surname><given-names>N</given-names></name>
<name><surname>Gubbels</surname><given-names>MJ</given-names></name>
</person-group>. <year>2008</year>. <article-title>Chemogenomics and parasitology: small molecules and cell-based assays to study infectious processes</article-title>. <source>Comb Chem High Throughput Screen</source>. <volume>11</volume>:<fpage>624</fpage>–<lpage>646</lpage>.</citation>
</ref>
<ref id="bibr58-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Newman</surname><given-names>JR</given-names></name>
<name><surname>Ghaemmaghami</surname><given-names>S</given-names></name>
<name><surname>Ihmels</surname><given-names>J</given-names></name>
<name><surname>Breslow</surname><given-names>DK</given-names></name>
<name><surname>Noble</surname><given-names>M</given-names></name>
<name><surname>DeRisi</surname><given-names>JL</given-names></name>
<name><surname>Weissman</surname><given-names>JS</given-names></name>
</person-group>. <year>2006</year>. <article-title>Single-cell proteomic analysis of <italic>S. cerevisiae</italic> reveals the architecture of biological noise</article-title>. <source>Nature</source>. <volume>441</volume>:<fpage>840</fpage>–<lpage>846</lpage>.</citation>
</ref>
<ref id="bibr59-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oberprieler</surname><given-names>NG</given-names></name>
<name><surname>Lemeer</surname><given-names>S</given-names></name>
<name><surname>Kalland</surname><given-names>ME</given-names></name>
<name><surname>Torgersen</surname><given-names>KM</given-names></name>
<name><surname>Heck</surname><given-names>AJR</given-names></name>
<name><surname>Tasken</surname><given-names>K</given-names></name>
</person-group>. <year>2010</year>. <article-title>High-resolution mapping of prostaglandin E2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8<sup>+</sup>CD45RO<sup>+</sup> T cells</article-title>. <source>Blood</source>. <volume>116</volume>:<fpage>2253</fpage>–<lpage>2265</lpage>.</citation>
</ref>
<ref id="bibr60-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oberprieler</surname><given-names>NG</given-names></name>
<name><surname>Tasken</surname><given-names>K</given-names></name>
</person-group>. <year>2011</year>. <article-title>Analysing phosphorylation-based signaling networks by phospho flow cytometry</article-title>. <source>Cell Signal</source>. <volume>23</volume>:<fpage>14</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr61-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oh</surname><given-names>ST</given-names></name>
<name><surname>Simonds</surname><given-names>EF</given-names></name>
<name><surname>Jones</surname><given-names>C</given-names></name>
<name><surname>Hale</surname><given-names>MB</given-names></name>
<name><surname>Goltsev</surname><given-names>Y</given-names></name>
<name><surname>Gibbs</surname><given-names>KD</given-names></name>
<name><surname>Merker</surname><given-names>JD</given-names></name>
<name><surname>Zehnder</surname><given-names>JL</given-names></name>
<name><surname>Nolan</surname><given-names>GP</given-names></name>
<name><surname>Gotlib</surname><given-names>J</given-names></name>
</person-group>. <year>2010</year>. <article-title>Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms</article-title>. <source>Blood</source>. <volume>116</volume>:<fpage>988</fpage>–<lpage>992</lpage>.</citation>
</ref>
<ref id="bibr62-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ortyn</surname><given-names>WE</given-names></name>
<name><surname>Hall</surname><given-names>BE</given-names></name>
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Frost</surname><given-names>K</given-names></name>
<name><surname>Basiji</surname><given-names>DA</given-names></name>
<name><surname>Perry</surname><given-names>DJ</given-names></name>
<name><surname>Zimmerman</surname><given-names>CA</given-names></name>
<name><surname>Coder</surname><given-names>D</given-names></name>
<name><surname>Morrissey</surname><given-names>PJ</given-names></name>
</person-group>. <year>2006</year>. <article-title>Sensitivity measurement and compensation in spectral imaging</article-title>. <source>Cytometry A</source>. <volume>69</volume>:<fpage>852</fpage>–<lpage>862</lpage>.</citation>
</ref>
<ref id="bibr63-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ouk</surname><given-names>C</given-names></name>
<name><surname>Jayat-Vignoles</surname><given-names>C</given-names></name>
<name><surname>Donnard</surname><given-names>M</given-names></name>
<name><surname>Feuillard</surname><given-names>J</given-names></name>
</person-group>. <year>2011</year>. <article-title>Both CD62 and CD162 antibodies prevent formation of CD36-dependent platelets, rosettes, and artefactual pseudoexpression of platelet markers on white blood cells: a study with Imagestream</article-title>. <source>Cytometry A</source>. <volume>79</volume>:<fpage>477</fpage>–<lpage>484</lpage>.</citation>
</ref>
<ref id="bibr64-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ozaki</surname><given-names>Y-I</given-names></name>
<name><surname>Uda</surname><given-names>S</given-names></name>
<name><surname>Saito</surname><given-names>TH</given-names></name>
<name><surname>Chung</surname><given-names>J</given-names></name>
<name><surname>Kubota</surname><given-names>H</given-names></name>
<name><surname>Kuroda</surname><given-names>S</given-names></name>
</person-group>. <year>2010</year>. <article-title>A quantitative image cytometry technique for time series or population analyses of signaling networks</article-title>. <source>PLoS One</source>. <volume>5</volume>:<fpage>e9955</fpage>.</citation>
</ref>
<ref id="bibr65-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ozbudak</surname><given-names>EM</given-names></name>
<name><surname>Thattai</surname><given-names>M</given-names></name>
<name><surname>Kurster</surname><given-names>I</given-names></name>
<name><surname>Grossman</surname><given-names>AD</given-names></name>
<name><surname>van Oudenaarden</surname><given-names>A</given-names></name>
</person-group>. <year>2002</year>. <article-title>Regulation of noise in the expression of a single gene</article-title>. <source>Nat Genet</source>. <volume>31</volume>:<fpage>69</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr66-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Perez</surname><given-names>OD</given-names></name>
<name><surname>Krutzik</surname><given-names>PO</given-names></name>
<name><surname>Nolan</surname><given-names>GP</given-names></name>
</person-group>. <year>2004</year>. <article-title>Flow cytometric analysis of kinase signaling cascades</article-title>. <source>Methods Mol Biol</source>. <volume>263</volume>:<fpage>67</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr67-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pilborough</surname><given-names>W</given-names></name>
<name><surname>Munro</surname><given-names>TP</given-names></name>
<name><surname>Gray</surname><given-names>P</given-names></name>
</person-group>. <year>2009</year>. <article-title>Intraclonal protein expression heterogeneity in recombinant CHO cells</article-title>. <source>PLoS One</source>. <volume>4</volume>:<fpage>e8432</fpage>.</citation>
</ref>
<ref id="bibr68-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pla-Roca</surname><given-names>M</given-names></name>
<name><surname>Leulmi</surname><given-names>RF</given-names></name>
<name><surname>Tourekhanova</surname><given-names>S</given-names></name>
<name><surname>Berqeron</surname><given-names>S</given-names></name>
<name><surname>Laforte</surname><given-names>V</given-names></name>
<name><surname>Moreau</surname><given-names>E</given-names></name>
<name><surname>Gosline</surname><given-names>SJ</given-names></name>
<name><surname>Bertos</surname><given-names>N</given-names></name>
<name><surname>Hallett</surname><given-names>M</given-names></name>
<name><surname>Park</surname><given-names>M</given-names></name><etal/>
</person-group>. <year>2012</year>. <article-title>Antibody colocalisation microarray: a scalable technology for multiplex protein analysis in complex samples</article-title>. <source>Mol Cell Proteomics</source>. <volume>11</volume>:<comment>M111.011460</comment>.</citation>
</ref>
<ref id="bibr69-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ploppa</surname><given-names>A</given-names></name>
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Unertl</surname><given-names>KE</given-names></name>
<name><surname>Nohe</surname><given-names>B</given-names></name>
<name><surname>Duriex</surname><given-names>ME</given-names></name>
</person-group>. <year>2011</year>. <article-title>ImageStream cytometry extends the analysis of phagocytosis and oxidative burst</article-title>. <source>Scand J Clin Lab Invest</source>. <volume>71</volume>:<fpage>362</fpage>–<lpage>369</lpage>.</citation>
</ref>
<ref id="bibr70-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ponomarev</surname><given-names>ED</given-names></name>
<name><surname>Veremeyko</surname><given-names>T</given-names></name>
<name><surname>Barteneva</surname><given-names>NS</given-names></name>
</person-group>. <year>2011</year>. <article-title>Visualization and quantitation of microRNAs and their target genes and neuroblastoma single cells using imaging cytometry</article-title>. <source>BMC Res Notes</source>. <volume>4</volume>:<fpage>517</fpage>.</citation>
</ref>
<ref id="bibr71-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pozarowski</surname><given-names>P</given-names></name>
<name><surname>Holden</surname><given-names>E</given-names></name>
<name><surname>Darzynkiewicz</surname><given-names>Z</given-names></name>
</person-group>. <year>2006</year>. <article-title>Laser scanning cytometry: principles and applications</article-title>. <source>Methods Mol Biol</source>. <volume>319</volume>:<fpage>165</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr72-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Radbruch</surname><given-names>A</given-names></name>
<name><surname>Recktenwald</surname><given-names>D</given-names></name>
</person-group>. <year>1995</year>. <article-title>Detection and isolation of rare cells</article-title>. <source>Curr Opin Immunol</source>. <volume>7</volume>:<fpage>270</fpage>–<lpage>273</lpage>.</citation>
</ref>
<ref id="bibr73-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Raj</surname><given-names>A</given-names></name>
<name><surname>Peskin</surname><given-names>CS</given-names></name>
<name><surname>Tranchina</surname><given-names>D</given-names></name>
<name><surname>Vargas</surname><given-names>DY</given-names></name>
<name><surname>Tyagi</surname><given-names>S</given-names></name>
</person-group>. <year>2006</year>. <article-title>Stochastic mRNA synthesis in mammalian cells</article-title>. <source>PLoS Biol</source>. <volume>4</volume>:<fpage>e309</fpage>.</citation>
</ref>
<ref id="bibr74-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rieger</surname><given-names>AM</given-names></name>
<name><surname>Hall</surname><given-names>BE</given-names></name>
<name><surname>Luong</surname><given-names>LT</given-names></name>
<name><surname>Schang</surname><given-names>LM</given-names></name>
<name><surname>Barreda</surname><given-names>DR</given-names></name>
</person-group>. <year>2010</year>. <article-title>Conventional apoptosis assays using propidium iodide generate a significant number of false positives that prevent accurate assessment of cell death</article-title>. <source>J Immunol Methods</source>. <volume>358</volume>:<fpage>81</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr75-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rimon</surname><given-names>N</given-names></name>
<name><surname>Schuldiner</surname><given-names>M</given-names></name>
</person-group>. <year>2011</year>. <article-title>Getting the whole picture: combining throughput with content in microscopy</article-title>. <source>J Cell Sci</source>. <volume>124</volume>:<fpage>3743</fpage>–<lpage>3751</lpage>.</citation>
</ref>
<ref id="bibr76-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shakulov</surname><given-names>VR</given-names></name>
<name><surname>Vorobjev</surname><given-names>IA</given-names></name>
<name><surname>Rubtsov</surname><given-names>YP</given-names></name>
<name><surname>Chichkova</surname><given-names>NV</given-names></name>
<name><surname>Vartapetian</surname><given-names>AB</given-names></name>
</person-group>. <year>2000</year>. <article-title>Interaction of yeast importin α with the NLS of prothymosin α is insufficient to trigger nuclear uptake of cargos</article-title>. <source>Biochem Biophys Res Commun</source>. <volume>274</volume>:<fpage>548</fpage>–<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr77-0022155412453052">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Shapiro</surname><given-names>HM</given-names></name>
</person-group>. <year>2005</year>. <article-title>Practical flow cytometry</article-title>. <publisher-loc>New York</publisher-loc>: <publisher-name>John Wiley</publisher-name>.</citation>
</ref>
<ref id="bibr78-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sigal</surname><given-names>A</given-names></name>
<name><surname>Milo</surname><given-names>R</given-names></name>
<name><surname>Cohen</surname><given-names>A</given-names></name>
<name><surname>Geva-Zatorsky</surname><given-names>N</given-names></name>
<name><surname>Klein</surname><given-names>Y</given-names></name>
<name><surname>Liron</surname><given-names>Y</given-names></name>
<name><surname>Rosenfeld</surname><given-names>N</given-names></name>
<name><surname>Danon</surname><given-names>T</given-names></name>
<name><surname>Perzov</surname><given-names>N</given-names></name>
<name><surname>Alon</surname><given-names>U</given-names></name>
</person-group>. <year>2006</year>. <article-title>Variability and memory of protein levels in human cells</article-title>. <source>Nature</source>. <volume>444</volume>:<fpage>643</fpage>–<lpage>646</lpage>.</citation>
</ref>
<ref id="bibr79-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>MV</given-names></name>
<name><surname>Davidson</surname><given-names>DC</given-names></name>
<name><surname>Kiebala</surname><given-names>M</given-names></name>
<name><surname>Maqqirwar</surname><given-names>SB</given-names></name>
</person-group>. <year>2012</year>. <article-title>Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1</article-title>. <source>J Virol Methods</source>. <volume>181</volume>:<fpage>170</fpage>–<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr80-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Starkuviene</surname><given-names>V</given-names></name>
<name><surname>Pepperkok</surname><given-names>R</given-names></name>
</person-group>. <year>2007</year>. <article-title>The potential of high-content high-throughput microscopy in drug discovery</article-title>. <source>Br J Pharmacol</source>. <volume>152</volume>:<fpage>62</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr81-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Teofili</surname><given-names>L</given-names></name>
<name><surname>Martini</surname><given-names>M</given-names></name>
<name><surname>Cenci</surname><given-names>T</given-names></name>
<name><surname>Petrucci</surname><given-names>G</given-names></name>
<name><surname>Torti</surname><given-names>L</given-names></name>
<name><surname>Storti</surname><given-names>S</given-names></name>
<name><surname>Guidi</surname><given-names>F</given-names></name>
<name><surname>Leone</surname><given-names>G</given-names></name>
<name><surname>Larocca</surname><given-names>LM</given-names></name>
</person-group>. <year>2007</year>. <article-title>Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation</article-title>. <source>Blood</source>. <volume>110</volume>:<fpage>354</fpage>–<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr82-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Terjung</surname><given-names>S</given-names></name>
<name><surname>Walter</surname><given-names>T</given-names></name>
<name><surname>Seitz</surname><given-names>A</given-names></name>
<name><surname>Neumann</surname><given-names>B</given-names></name>
<name><surname>Pepperkok</surname><given-names>R</given-names></name>
<name><surname>Ellenberg</surname><given-names>J</given-names></name>
</person-group>. <year>2010</year>. <article-title>High-throughput microscopy using live mammalian cells</article-title>. <source>Cold Spring Harb Protoc</source>. <volume>7</volume>:<comment>pdb.top84</comment>.doi:<pub-id pub-id-type="doi">10.1101/pdb.top84</pub-id>.</citation>
</ref>
<ref id="bibr83-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tibrewal</surname><given-names>N</given-names></name>
<name><surname>Wu</surname><given-names>Y</given-names></name>
<name><surname>D’mello</surname><given-names>V</given-names></name>
<name><surname>Akakura</surname><given-names>R</given-names></name>
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Varnum</surname><given-names>B</given-names></name>
<name><surname>Birge</surname><given-names>RB</given-names></name>
</person-group>. <year>2008</year>. <article-title>Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipoplysaccharide-inducible NF-kappaB transcriptional activation</article-title>. <source>J Biol Chem</source>. <volume>283</volume>:<fpage>3618</fpage>–<lpage>3627</lpage>.</citation>
</ref>
<ref id="bibr84-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsuru</surname><given-names>S</given-names></name>
<name><surname>Ichinose</surname><given-names>J</given-names></name>
<name><surname>Kashiwagi</surname><given-names>A</given-names></name>
<name><surname>Ying</surname><given-names>BW</given-names></name>
<name><surname>Kaneko</surname><given-names>K</given-names></name>
<name><surname>Yomo</surname><given-names>T</given-names></name>
</person-group>. <year>2009</year>. <article-title>Noisy cell growth rate leads to fluctuating protein concentration in bacteria</article-title>. <source>Phys Biol</source>. <volume>6</volume>:<fpage>036015</fpage>.</citation>
</ref>
<ref id="bibr85-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tu</surname><given-names>L-C</given-names></name>
<name><surname>Musser</surname><given-names>SM</given-names></name>
</person-group>. <year>2011</year>. <article-title>Single molecule studies of nucleocytoplasmic transport</article-title>. <source>Biochim Biophys Acta</source>. <volume>1813</volume>:<fpage>1607</fpage>–<lpage>1618</lpage>.</citation>
</ref>
<ref id="bibr86-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vallhov</surname><given-names>H</given-names></name>
<name><surname>Gutzeit</surname><given-names>C</given-names></name>
<name><surname>Johansson</surname><given-names>SM</given-names></name>
<name><surname>Nagy</surname><given-names>N</given-names></name>
<name><surname>Paul</surname><given-names>M</given-names></name>
<name><surname>Li</surname><given-names>Q</given-names></name>
<name><surname>Friend</surname><given-names>S</given-names></name>
<name><surname>George</surname><given-names>TC</given-names></name>
<name><surname>Klein</surname><given-names>E</given-names></name>
<name><surname>Scheynius</surname><given-names>A</given-names></name><etal/>
</person-group>. <year>2011</year>. <article-title>Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro</article-title>. <source>J Immunol</source>. <volume>186</volume>:<fpage>73</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr87-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Volfson</surname><given-names>D</given-names></name>
<name><surname>Marciniak</surname><given-names>J</given-names></name>
<name><surname>Blake</surname><given-names>WJ</given-names></name>
<name><surname>Ostroff</surname><given-names>N</given-names></name>
<name><surname>Tsimring</surname><given-names>LS</given-names></name>
<name><surname>Hasty</surname><given-names>J</given-names></name>
</person-group>. <year>2006</year>. <article-title>Origins of extrinsic variability in eukaryotic gene expression</article-title>. <source>Nature</source>. <volume>439</volume>:<fpage>861</fpage>–<lpage>864</lpage>.</citation>
</ref>
<ref id="bibr88-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>S</given-names></name>
<name><surname>Jin</surname><given-names>L</given-names></name>
<name><surname>Vence</surname><given-names>L</given-names></name>
<name><surname>Radvanyi</surname><given-names>LG</given-names></name>
</person-group>. <year>2010</year>. <article-title>Development and application of “phosphoflow” as a tool for immunomonitoring</article-title>. <source>Expert Rev Vaccines</source>. <volume>9</volume>:<fpage>631</fpage>–<lpage>643</lpage>.</citation>
</ref>
<ref id="bibr89-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>C</given-names></name>
<name><surname>Lo</surname><given-names>A</given-names></name>
<name><surname>Yammanuru</surname><given-names>A</given-names></name>
<name><surname>Tallarico</surname><given-names>AS</given-names></name>
<name><surname>Brady</surname><given-names>K</given-names></name>
<name><surname>Murakami</surname><given-names>A</given-names></name>
<name><surname>Barteneva</surname><given-names>N</given-names></name>
<name><surname>Zhu</surname><given-names>Q</given-names></name>
<name><surname>Marasco</surname><given-names>WA</given-names></name>
</person-group>. <year>2010</year>. <article-title>Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology</article-title>. <source>PLoS One</source>. <volume>5</volume>:<fpage>e9625</fpage>.</citation>
</ref>
<ref id="bibr90-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname><given-names>J</given-names></name>
<name><surname>Xiao</surname><given-names>J</given-names></name>
<name><surname>Ren</surname><given-names>X</given-names></name>
<name><surname>Lao</surname><given-names>K</given-names></name>
<name><surname>Xie</surname><given-names>XS</given-names></name>
</person-group>. <year>2006</year>. <article-title>Probing gene expression in live cells, one protein molecule at a time</article-title>. <source>Science</source>. <volume>311</volume>:<fpage>1600</fpage>–<lpage>1603</lpage>.</citation>
</ref>
<ref id="bibr91-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>F</given-names></name>
<name><surname>Hu</surname><given-names>J</given-names></name>
<name><surname>Ma</surname><given-names>H</given-names></name>
<name><surname>Harrison</surname><given-names>ML</given-names></name>
<name><surname>Geahlen</surname><given-names>RL</given-names></name>
</person-group>. <year>2006</year>. <article-title>Nucleocytoplasmic trafficking of the Syk protein tyrosine kinase</article-title>. <source>Mol Cell Biol</source>. <volume>26</volume>:<fpage>3478</fpage>–<lpage>3491</lpage>.</citation>
</ref>
<ref id="bibr92-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zuba-Surma</surname><given-names>EK</given-names></name>
<name><surname>Klich</surname><given-names>I</given-names></name>
<name><surname>Greco</surname><given-names>N</given-names></name>
<name><surname>Laughlin</surname><given-names>M</given-names></name>
<name><surname>Ratajczak</surname><given-names>J</given-names></name>
<name><surname>Ratajczak</surname><given-names>MZ</given-names></name>
</person-group>. <year>2009</year>. <article-title>Optimization of isolation and further characterization of umbilical cord blood–derived very small embryonic/epiblast-like stem cells</article-title>. <source>Eur J Hematol</source>. <volume>84</volume>:<fpage>34</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr93-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zuba-Surma</surname><given-names>EK</given-names></name>
<name><surname>Kucia</surname><given-names>M</given-names></name>
<name><surname>Ratajczak</surname><given-names>J</given-names></name>
<name><surname>Ratajczak</surname><given-names>MZ</given-names></name>
</person-group>. <year>2009</year>. <article-title>“Small stem cells” in adult tissues: very small embryonic-like stem cells stand up!</article-title> <source>Cytometry A</source>. <volume>75</volume>:<fpage>4</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr94-0022155412453052">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zuba-Surma</surname><given-names>EK</given-names></name>
<name><surname>Kucia</surname><given-names>M</given-names></name>
<name><surname>Rui</surname><given-names>L</given-names></name>
<name><surname>Shin</surname><given-names>DM</given-names></name>
<name><surname>Wojakowski</surname><given-names>W</given-names></name>
<name><surname>Ratajczak</surname><given-names>J</given-names></name>
<name><surname>Ratajczak</surname><given-names>MZ</given-names></name>
</person-group>. <year>2009</year>. <article-title>Fetal liver very small embryonic/epiblast like stem cells follow developmental migratory pathway of hematopoietic stem cells</article-title>. <source>Ann NY Acad Sci</source>. <volume>1176</volume>:<fpage>205</fpage>–<lpage>218</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>